Health & Medicine

Diseases & Treatments

Covid-19, a drug with questions

Émission

Le 19h30
27 December 2021

Oriol Manuel

CHUV

Biologie et de médecine, UNIL

"Ronapreve" is the first Covid-19 drug to be approved in Switzerland. However, its efficacy against the Omicron variant has already been questioned.

Related interventions

Sections

Health & Medicine

Diseases & Treatments

Switzerland authorizes first Covid-19 drug

- Alexandra Calmy
  
  HUG | UNIGE

27 December 2021

Sections

Health & Medicine

Diseases & Treatments

Update on new vaccines approved in Switzerland

- Blaise Genton
  
  CHUV | UNIL

04 February 2021

Sections

Health & Medicine

Diseases & Treatments

Samia Hurst: "The Omicron variant has lost its seasonality"

- Samia Hurst-Majno
  
  UNIGE

20 July 2022

Sections

Health & Medicine

Diseases & Treatments

What do we know about the Omicron variant?

- Antoine Flahault
  
  UNIGE

30 November 2021

Sections

Health & Medicine

Diseases & Treatments

Colchicine and Covid: a real breakthrough or a media stunt?

- Thomas Agoritsas
  
  HUG | UNIGE

27 January 2021

Sections

Health & Medicine

Diseases & Treatments

The new Omicron variant present in several countries

- Pauline Vetter
  
  HUG

27 November 2021

Sections

Health & Medicine

Diseases & Treatments

FDA clears synthetic antibodies against Covid

- Jean Villard
  
  HUG | UNIGE

24 November 2020

Sections

Health & Medicine

Diseases & Treatments

The Omicron variant may already be circulating in Switzerland

- Samia Hurst-Majno
  
  UNIGE

29 November 2021